AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 104 filers reported holding AKERO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $682,029 | -54.5% | 29,072 | -51.0% | 0.00% | 0.0% |
Q1 2024 | $1,497,766 | -69.8% | 59,294 | -72.1% | 0.00% | -83.3% |
Q4 2023 | $4,955,150 | +64.6% | 212,212 | +256.5% | 0.01% | +50.0% |
Q3 2023 | $3,010,572 | +81.8% | 59,521 | +67.8% | 0.00% | +100.0% |
Q2 2023 | $1,656,281 | -32.9% | 35,474 | -45.0% | 0.00% | -33.3% |
Q1 2023 | $2,468,420 | +19.3% | 64,517 | +70.9% | 0.00% | 0.0% |
Q4 2022 | $2,069,248 | -99.6% | 37,760 | +158.3% | 0.00% | +200.0% |
Q3 2022 | $497,743,000 | +135.2% | 14,618 | -34.7% | 0.00% | – |
Q2 2022 | $211,661,000 | +126.7% | 22,398 | +240.3% | 0.00% | – |
Q1 2022 | $93,384,000 | -22.5% | 6,581 | +15.5% | 0.00% | – |
Q4 2021 | $120,470,000 | +12.3% | 5,696 | +18.7% | 0.00% | – |
Q3 2021 | $107,235,000 | +359.3% | 4,798 | +409.9% | 0.00% | – |
Q2 2021 | $23,346,000 | -53.3% | 941 | -45.4% | 0.00% | – |
Q1 2021 | $49,955,000 | +45.7% | 1,722 | +29.6% | 0.00% | – |
Q4 2020 | $34,288,000 | -63.9% | 1,329 | -56.9% | 0.00% | – |
Q3 2020 | $94,864,000 | +785.3% | 3,081 | +616.5% | 0.00% | – |
Q2 2020 | $10,716,000 | -79.6% | 430 | -82.6% | 0.00% | – |
Q1 2020 | $52,470,000 | +320.6% | 2,475 | +340.4% | 0.00% | – |
Q4 2019 | $12,474,000 | -9.2% | 562 | -7.0% | 0.00% | – |
Q3 2019 | $13,741,000 | – | 604 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
University of Wisconsin Foundation | 423,849 | $9,943,498 | 11.19% |
Propel Bio Management, LLC | 327,752 | $7,689,062 | 4.99% |
GENERAL ATLANTIC, L.P. | 5,233,989 | $122,789,382 | 3.86% |
SILVERARC CAPITAL MANAGEMENT, LLC | 625,087 | $14,664,541 | 3.46% |
Yiheng Capital Management, L.P. | 1,434,179 | $33,645,839 | 2.71% |
Redmile Group, LLC | 1,614,473 | $37,875,537 | 2.29% |
Boxer Capital, LLC | 1,676,733 | $39,336,156 | 2.07% |
RTW INVESTMENTS, LP | 5,431,985 | $127,434,368 | 1.97% |
Logos Global Management LP | 800,000 | $18,768,000 | 1.52% |
MPM BioImpact LLC | 385,990 | $9,055,325 | 1.41% |